Articles

More 3D mammography

FUJIFILM Medical Systems U.S.A., Inc. announces nine additional healthcare systems which have chosen their ASPIRE Cristalle mammography systems with 3D imaging
Brought to you byDDNews Staff
| 2 min read

STAMFORD, Conn.—Today, FUJIFILM Medical Systems U.S.A., Inc., a provider of diagnostic imaging products including digital radiography and women's health solutions, announced nine of the initial healthcare systems across the United States which have selected Fujifilm's ASPIRE Cristalle mammography system with 3D imaging or Digital Breast Tomosynthesis (DBT) option in order to improve their diagnostic imaging capabilities and patient outcomes.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Researcher examining a multiwell plate alongside cell culture dishes in a laboratory.
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Abstract rainbow-colored beams of light spreading across a dark background.
Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.
Illustration of multiple glowing blue and purple spherical cells against a dark blue background.
As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.